MX2008013728A - Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo. - Google Patents

Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo.

Info

Publication number
MX2008013728A
MX2008013728A MX2008013728A MX2008013728A MX2008013728A MX 2008013728 A MX2008013728 A MX 2008013728A MX 2008013728 A MX2008013728 A MX 2008013728A MX 2008013728 A MX2008013728 A MX 2008013728A MX 2008013728 A MX2008013728 A MX 2008013728A
Authority
MX
Mexico
Prior art keywords
group
salt
therapeutic agent
amino
alkyl ether
Prior art date
Application number
MX2008013728A
Other languages
English (en)
Inventor
Noboru Iwakami
Shigeki Marubuchi
Tomohiro Okuda
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of MX2008013728A publication Critical patent/MX2008013728A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se divulga un agente que consta de un derivado de éter de alquil-benzotiofeno representado por la fórmula general que se describe abajo o una sal del mismo: (ver fórmula I) en donde R1 y R2 representan de manera independiente por lo menos uno de los grupos seleccionados de un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo, un grupo arilo, un grupo aralquilo, un grupo alcoxi, un grupo ariloxi, un grupo alquiltio, un grupo ariltio, un grupo alquenilo, un grupo alqueniloxi, un grupo alquilsulfonilo, un grupo carbamoilo, un grupo heterocíclico, un grupo amino, grupo hidroxilo, un grupo carboxilo, un grupo nitro, un grupo oxo y similares; R3 representa un grupo alquilamino que puede ser sustituido o un grupo amino o un grupo hidroxilo que se puede proteger; y m y n representan de manera independiente un número entero de 1 a 6. El agente es útil como inductor de neurogénesis o un agente terapéutico para neuropatía.
MX2008013728A 2006-04-26 2007-04-24 Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo. MX2008013728A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006122080 2006-04-26
PCT/JP2007/058841 WO2007125913A1 (ja) 2006-04-26 2007-04-24 アルキルエーテル誘導体またはその塩を含有する神経細胞新生誘導剤および精神障害治療剤

Publications (1)

Publication Number Publication Date
MX2008013728A true MX2008013728A (es) 2009-01-07

Family

ID=38655439

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008013728A MX2008013728A (es) 2006-04-26 2007-04-24 Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo.

Country Status (20)

Country Link
US (1) US20090093453A1 (es)
EP (1) EP2011796B1 (es)
JP (2) JP5695293B2 (es)
KR (1) KR101374593B1 (es)
CN (1) CN101432280B (es)
AU (1) AU2007244409B2 (es)
BR (1) BRPI0710239A2 (es)
CA (1) CA2648898C (es)
CY (1) CY1115643T1 (es)
DK (1) DK2011796T3 (es)
ES (1) ES2518371T3 (es)
IL (1) IL194569A (es)
MX (1) MX2008013728A (es)
NO (1) NO342153B1 (es)
NZ (1) NZ571975A (es)
PL (1) PL2011796T3 (es)
PT (1) PT2011796E (es)
SI (1) SI2011796T1 (es)
WO (1) WO2007125913A1 (es)
ZA (1) ZA200808728B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101643470B (zh) 2001-10-19 2012-08-01 富山化学工业株式会社 烷基醚衍生物或其盐
IL165589A (en) 2002-06-14 2012-04-30 Toyama Chemical Co Ltd Pharmaceutical preparation to improve brain function and use
CA2799659C (en) * 2005-03-28 2014-12-02 Toyama Chemical Co., Ltd. Process for production of 1-(3-(2-(1-benzothiophen-5-yl) ethoxy)propyl) azetidin-3-ol or salts thereof
CA2659835A1 (en) * 2006-08-04 2008-02-07 Toyama Chemical Co., Ltd. Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
ES2465005T3 (es) * 2008-05-28 2014-06-04 Toyama Chemical Co., Ltd. Derivado de óxido de benzotiofeno y sus sales
EP3044207B1 (en) * 2013-09-12 2017-10-18 F. Hoffmann-La Roche AG Indol-carboxamide derivatives
ES2792950T3 (es) 2014-01-31 2020-11-12 Fujifilm Toyama Chemical Co Ltd Agente potenciador del efecto de rehabilitación después de una lesión nerviosa que comprende un derivado alquil éter o una sal del mismo
US10238632B2 (en) 2015-06-11 2019-03-26 Fujifilm Toyama Chemical Co., Ltd. Sigma receptor-binding agent
JP6860502B2 (ja) * 2015-12-25 2021-04-14 富士フイルム富山化学株式会社 １−（３−（２−（１−ベンゾチオフェン−５−イル）エトキシ）プロピル）アゼチジン−３−オールまたはその塩を含む錠剤
CN110139641B (zh) * 2016-12-28 2022-09-09 富士胶片富山化学株式会社 外用组合物
RU2019138538A (ru) 2017-06-02 2021-07-09 ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. СРЕДСТВО ДЛЯ УМЕНЬШЕНИЯ КОЛИЧЕСТВА АМИЛОИДНОГО β-БЕЛКА
RU2759727C2 (ru) * 2017-06-02 2021-11-17 ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. Средство для профилактики или лечения атрофии головного мозга
WO2018221728A1 (ja) 2017-06-02 2018-12-06 富山化学工業株式会社 アルツハイマー型認知症予防または治療剤
KR20190138696A (ko) * 2017-06-02 2019-12-13 후지필름 도야마 케미컬 가부시키가이샤 척수 소뇌 변성증 예방 또는 치료제
JP7227914B2 (ja) 2017-10-30 2023-02-22 富士フイルム富山化学株式会社 エモパミル結合タンパク質結合剤およびその利用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294346B1 (en) * 1991-07-08 2001-09-25 Neurospheres Holdings, Ltd. Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
JPH05284992A (ja) * 1992-04-14 1993-11-02 Sagami Chem Res Center 神経成長因子産生促進剤及びその製造法
GB9309749D0 (en) * 1993-05-12 1993-06-23 Boots Co Plc Therapeutic agents
JPH07285912A (ja) * 1994-04-19 1995-10-31 Asahi Chem Ind Co Ltd 新規化合物ａｍ５２２１
JP2733207B2 (ja) * 1995-05-18 1998-03-30 工業技術院長 繊維芽細胞成長因子キメラ蛋白質を含有する医薬組成物
AU1506499A (en) * 1997-12-12 1999-07-05 Toyama Chemical Co. Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
IL129178A0 (en) * 1999-03-25 2000-02-17 Yeda Res & Dev Induction of nerve generation
NZ515706A (en) * 1999-06-11 2003-08-29 Toyama Chemical Co Ltd N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
US20040030131A1 (en) * 2000-10-04 2004-02-12 Martine Keenan Pharmaceutical compounds
GB2367554A (en) * 2000-10-04 2002-04-10 Lilly Co Eli Pharmacologically active amines
JP4303435B2 (ja) * 2001-02-26 2009-07-29 富山化学工業株式会社 ミトコンドリア機能賦活剤
US7208495B2 (en) * 2001-07-05 2007-04-24 Takeda Pharmaceutical Company Limited Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
JP4357802B2 (ja) * 2001-07-05 2009-11-04 武田薬品工業株式会社 ベンゼン環縮合５員複素環式化合物、その製造法および用途
JP4905752B2 (ja) * 2001-07-24 2012-03-28 エスティー・ラボ株式会社 揮発性有機塩素化合物センサ
CN101643470B (zh) * 2001-10-19 2012-08-01 富山化学工业株式会社 烷基醚衍生物或其盐
JP4537011B2 (ja) * 2002-03-01 2010-09-01 武田薬品工業株式会社 抗うつ剤
IL165589A (en) * 2002-06-14 2012-04-30 Toyama Chemical Co Ltd Pharmaceutical preparation to improve brain function and use
JP2004256428A (ja) * 2003-02-25 2004-09-16 Science Univ Of Tokyo 神経栄養因子様プリン系化合物含有作用剤
KR101096528B1 (ko) * 2003-04-17 2011-12-20 토야마 케미칼 컴퍼니 리미티드 알킬에테르 유도체 또는 그 염을 함유하는 망막신경질환의예방·치료제
WO2005032535A1 (ja) * 2003-10-03 2005-04-14 Ono Pharmaceutical Co., Ltd. 神経再生促進剤

Also Published As

Publication number Publication date
ZA200808728B (en) 2010-01-27
CY1115643T1 (el) 2017-01-04
PT2011796E (pt) 2014-11-26
CN101432280A (zh) 2009-05-13
CA2648898C (en) 2015-01-20
DK2011796T3 (da) 2014-10-27
KR20080111131A (ko) 2008-12-22
JP2013177410A (ja) 2013-09-09
CN101432280B (zh) 2012-11-21
NO20084338L (no) 2008-11-19
AU2007244409B2 (en) 2011-12-01
KR101374593B1 (ko) 2014-03-17
AU2007244409A1 (en) 2007-11-08
CA2648898A1 (en) 2007-11-08
EP2011796A1 (en) 2009-01-07
JP5695293B2 (ja) 2015-04-01
BRPI0710239A2 (pt) 2011-08-09
PL2011796T3 (pl) 2015-03-31
US20090093453A1 (en) 2009-04-09
JPWO2007125913A1 (ja) 2009-09-10
SI2011796T1 (sl) 2015-02-27
IL194569A0 (en) 2009-08-03
EP2011796B1 (en) 2014-10-08
IL194569A (en) 2014-09-30
NZ571975A (en) 2011-04-29
WO2007125913A1 (ja) 2007-11-08
EP2011796A4 (en) 2010-07-07
NO342153B1 (no) 2018-04-03
ES2518371T3 (es) 2014-11-05

Similar Documents

Publication Publication Date Title
MX2008013728A (es) Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo.
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
TN2011000422A1 (en) Benzofuran derivatives
MX2010002820A (es) Analogos de tiazolidindiona para tratamiento de hipertension.
TW200745034A (en) New compounds
MX2008012399A (es) Modulacion de cinasa de ceramida.
RS20060699A (en) Isoxazolines for controlling inverterbrate pests
MX2009012885A (es) Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
TW200730514A (en) Morpholine type cinnamide compound
WO2009156861A3 (en) Substituted pyrimidone derivatives
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
MX2009001255A (es) Agente mejorador de la actividad de la proteina qunasa c que contiene un derivado de alquileter o una sal del mismo.
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
TN2011000429A1 (en) Derivatives of benzothiazines, preparation thereof and application thereof as drugs
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
TW200719894A (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
SG165381A1 (en) Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
UA86077C2 (en) Cetp inhibitors
PL1904469T3 (pl) Nowe pochodne pirokatechiny
TW200700419A (en) 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds

Legal Events

Date Code Title Description
FG Grant or registration